
IndraLab
Statements
sparser
"The direct block was mediated by drug binding to S6 domain of the hERG subunit, while trafficking deficiency was mediated by binding to a different site or a related protein. xref In this study, we used site-directed mutagenesis to test whether Y652A or F656V mutation alter the BBR sensitivity of hERG after long-term treatment."
sparser
"Interestingly, one d-sotalol (0) or l-sotalol(+) molecule was observed to bind deep into the hERG pore, just below the SF region and interact with the canonical drug binding F656 and Y652 hERG residues [ xref – xref ] in the pore lining S6 helices (drug molecule M2 in xref and xref ) for most of 8 μs long MD runs, while another drug molecule was observed to transiently bind below, interacting with F656 and/or Y652 from another domain as well as S660 and other residues at the bottom of S6 helices (M1 in xref and xref )."
sparser
"Interestingly, for l-sotalol(0) and d-sotalol(+) systems, we observed only transient binding of one or two drug molecules at the bottom of hERG channel pore interacting with S660 and other S6 helix residues there ( xref and xref and xref and xref ) Hence up to two sotalol molecules were able to bind to the hERG pore, in agreement with our electrophysiological data (as described below)."